University of Arizona researchers uncovered how levodopa-induced dyskinesia disrupts motor cortex function in Parkinson’s patients. Exploring ketamine as a treatment, they found it promotes neuroplasticity and restores control over movement.

An “extraordinary” brain network discovery shows that Parkinson’s disease may not be a movement disorder after all